Michael R Charlton Selected Research

Michael R Charlton Research Topics

Disease

18	Fibrosis (Cirrhosis) 01/2024 - 04/2002
16	Infections 11/2023 - 04/2002
14	Non-alcoholic Fatty Liver Disease 01/2024 - 08/2011
11	Hepatocellular Carcinoma (Hepatoma) 01/2020 - 03/2007
9	Hepatitis C 02/2016 - 01/2002
8	Chronic Hepatitis C 02/2016 - 04/2002
6	Liver Diseases (Liver Disease) 11/2023 - 04/2002
5	Liver Cirrhosis (Hepatic Cirrhosis) 01/2024 - 09/2011
4	Obesity 01/2018 - 06/2006
3	Neoplasms (Cancer) 01/2020 - 04/2002
3	Inflammation (Inflammations) 01/2018 - 06/2006
2	Chronic Hepatitis B 09/2020 - 06/2003
2	Fatty Liver 01/2020 - 05/2014
2	Alcoholic Fatty Liver 01/2019 - 01/2018
2	Heart Diseases (Heart Disease) 01/2017 - 01/2011
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2017 - 01/2011
2	Alcoholic Liver Diseases (Alcoholic Liver Disease) 01/2016 - 11/2012
2	Disease Progression 09/2014 - 07/2003
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 08/2014 - 07/2010
2	Hepatitis 05/2014 - 10/2002
2	Insulin Resistance 09/2011 - 06/2006
2	Hypertension (High Blood Pressure) 01/2011 - 08/2010
2	End Stage Liver Disease 08/2010 - 04/2005
2	Autoimmune Hepatitis 04/2005 - 07/2003
1	Nausea 01/2024
1	Diarrhea 01/2024
1	Hepatic Encephalopathy 11/2023
1	Liver Failure 11/2023
1	Dysbiosis 01/2023
1	Bone Diseases (Bone Disease) 09/2020
1	Coinfection 01/2020
1	Dyslipidemias (Dyslipidemia) 01/2020
1	Melanoma (Melanoma, Malignant) 01/2020
1	Necrosis 01/2018
1	Virus Diseases (Viral Diseases) 02/2016
1	Alcoholic Hepatitis 01/2016
1	Hepatitis E 09/2015
1	Chronic Renal Insufficiency 09/2014
1	Anemia 05/2014
1	Overweight 08/2013

Drug/Important Bio-Agent (IBA)

6	Biomarkers (Surrogate Marker)IBA 01/2024 - 05/2015
6	Antiviral Agents (Antivirals)IBA 01/2020 - 04/2002
4	Ribavirin (Virazole)FDA LinkGeneric 09/2015 - 06/2006
3	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 04/2002
3	InterferonsIBA 05/2014 - 06/2006
2	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2020 - 06/2003
2	Proteins (Proteins, Gene)FDA Link 01/2020 - 09/2011
2	Alanine Transaminase (SGPT)IBA 01/2020 - 01/2013
2	nasIBA 01/2019 - 07/2003
2	selonsertibIBA 01/2019 - 01/2018
2	alpha-Fetoproteins (alpha-Fetoprotein)IBA 05/2015 - 03/2007
2	telaprevirIBA 05/2014 - 07/2013
2	RNA (Ribonucleic Acid)IBA 01/2013 - 09/2010
2	CreatinineIBA 09/2012 - 08/2010
2	SteroidsIBA 12/2011 - 09/2002
1	resmetiromIBA 01/2024
1	Thyroid Hormone Receptors beta (TR beta)IBA 01/2024
1	Bile Acids and Salts (Bile Acids)IBA 11/2023
1	Anti-Bacterial Agents (Antibiotics)IBA 11/2023
1	Lactulose (Duphalac)FDA LinkGeneric 11/2023
1	DisaccharidesIBA 11/2023
1	Volatile Fatty AcidsIBA 11/2023
1	CholesterolIBA 01/2023
1	FructoseIBA 01/2023
1	Glucose (Dextrose)FDA LinkGeneric 01/2023
1	Drinking WaterIBA 01/2023
1	tenofovir alafenamideIBA 09/2020
1	entecavir FDA Link 09/2020
1	Tenofovir (Viread)FDA Link 09/2020
1	Messenger RNA (mRNA)IBA 01/2020
1	Hepatitis B e AntigensIBA 01/2020
1	pembrolizumabIBA 01/2020
1	NivolumabIBA 01/2020
1	IpilimumabIBA 01/2020
1	SulfatasesIBA 01/2020
1	Protons (Proton)IBA 01/2019
1	Tumor Biomarkers (Tumor Markers)IBA 03/2018
1	simtuzumabIBA 01/2018
1	CollagenIBA 01/2018
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2018
1	MAP Kinase Kinase Kinase 5IBA 01/2018
1	Protein Kinases (Protein Kinase)IBA 04/2016
1	Fatty Acids (Saturated Fatty Acids)IBA 04/2016
1	fasudil (AT 877)IBA 04/2016
1	LipidsIBA 04/2016
1	PalmitatesIBA 04/2016
1	TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA 04/2016
1	Neutralizing AntibodiesIBA 09/2014
1	AntibodiesIBA 09/2014
1	Broadly Neutralizing AntibodiesIBA 09/2014
1	Serum AlbuminIBA 08/2014
1	Erythropoietin FDA Link 05/2014
1	Growth Hormone (Somatotropin)IBA 05/2014

Therapy/Procedure

36	Liver Transplantation 01/2019 - 04/2002
8	Therapeutics 01/2024 - 04/2002
7	Transplantation 01/2016 - 04/2002
2	Bariatric Surgery 01/2018 - 11/2011
2	Drug Tapering 05/2014 - 07/2013
1	Immunotherapy 01/2020
1	Drug Therapy (Chemotherapy) 05/2016